Roger Hesselstrand
1 – 10 of 169
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension
(
- Contribution to journal › Article
- 2022
-
Mark
N-Formyl Methionine Peptide-Mediated Neutrophil Activation in Systemic Sclerosis
(
- Contribution to journal › Article
-
Mark
Validity and reliability of the Swedish version of the Self-Efficacy for Managing Chronic Disease scale for individuals with systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Atrioventricular plane displacement and regional function to predict outcome in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Development and validation of a patient-reported outcome measure for systemic sclerosis : the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire
(
- Contribution to journal › Article
-
Mark
Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Disease Features and Gastrointestinal Microbial Composition in Patients with Systemic Sclerosis from Two Independent Cohorts
(
- Contribution to journal › Article
-
Mark
Recommendations for the execution and reporting of skin ultrasound in systemic sclerosis : an international collaboration under the WSF skin ultrasound group
(
- Contribution to journal › Scientific review
-
Mark
Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension
(
- Contribution to journal › Article